Quantcast

Latest Retinitis pigmentosa Stories

2009-08-25 15:24:18

A team of scientists from the University of Wisconsin-Madison School of Medicine and Public Health has successfully grown multiple types of retina cells from two types of stem cells "” suggesting a future in which damaged retinas could be repaired by cells grown from the patient's own skin.Even sooner, the discovery will lead to laboratory models for studying genetically linked eye conditions, screening new drugs to treat those conditions and understanding the development of the human...

2009-08-25 01:30:00

TOKYO, Aug. 25 /PRNewswire/ -- We are pleased to announce that subject enrollment for the phase 2 clinical study of 0.15% UF-021 (generic name; isopropyl unoprostone; active ingredient of Rescula(R) eye-drops) in patients with retinitis pigmentosa has been completed. We submitted the notification of the clinical trial in August 2008. Enrollment in the phase 2 study began at six clinical sites in late December 2008 and was completed on August 3, 2009. The clinical study has progressed with...

d1237549c8aff2512db94251a60574691
2009-08-13 12:43:36

U.S. researchers said on Wednesday that a year after receiving gene therapy for a condition that causes total blindness by age 30, three people continue to see better and one has improved enough to read the digital numbers on a clock, Reuters reported. Doctors involved in the experiment reported in the New England Journal of Medicine that improvements in the vision of the three volunteers, who were all in their 20s and legally blind, has not deteriorated over time. One of the subjects has...

2009-07-08 22:40:08

People with poor eyesight caused by diseases often can be helped with various vision aids, a U.S. newsletter says. Experts at the Mayo Clinic Women's HealthSource say such low vision isn't just the normal trouble people have reading small print as they get older. It's limited vision caused by macular degeneration, glaucoma, cataracts, diabetic retinopathy, retinitis pigmentosa or other eye diseases. A low vision specialist can help patients find the vision aids that will best serve them, the...

187e433136017eff726dd25d732a44ec1
2009-07-08 09:40:00

Scientists use a new technique consisting of the induction of neuronal degeneration for intense light exposure in the mouse's retina, an experimental model of retinitis pigmentosa. Their work is based on the study of microglial cells, practically involved in all the diseases and damages of the nervous system, including Parkinson y Alzheimer.Researchers of the University of Granada (Spain) have used a technique consisting of the induction of neuronal degeneration neuronal for intense light...

2009-06-26 09:44:11

Research lead by Dr. Nicolas Bazan, Boyd Professor and Director of the Neuroscience Center of Excellence at LSU Health Sciences Center New Orleans, identifying an enzyme that makes neuroprotectin D1 which specifically and selectively protects retinal cells key for vision, will be published in the June 26, 2009 issue of the Journal of Biological Chemistry.Dr. Bazan's research team previously discovered neuroprotectin D1 (NPD1), a naturally produced chemical messenger that protects cells from...

2009-06-11 15:39:26

Advanced Cell Technology, Inc. (OTC:ACTC.PK) and its collaborators at OHSU reported today the long-term safety and efficacy of human embryonic stem cell (hESC)-derived retinal pigment epithelium (RPE) produced under manufacturing conditions suitable for human clinical trials. Two important early potential hESC applications are the use of RPE for the treatment of age-related macular degeneration and Stargardt disease, an untreatable form of eye disease that leads to early-onset blindness. The...

2009-06-10 09:35:00

Walkers Raised $3000 to Help Fund Sight-Saving Research Through Foundation Fighting Blindness DALLAS, June 10 /PRNewswire/ -- Principal Management Group of North Texas (PMG), an Associa Company, recently participated in a walk-a-thon as "Bonnie Believers" in support of the Greater DFW Chapter of the Foundation Fighting Blindness, Inc. (FFB). The walk-a-thon is the 2nd annual for Dallas and is the signature fundraiser for Foundation Fighting Blindness, Inc. Over 350 participants joined in...

2009-05-28 07:32:00

LINCOLN, R.I., May 28 /PRNewswire/ -- Neurotech Pharmaceuticals, Inc. today announced that the Company's product candidate, NT-501, demonstrated a strong biologic effect in two Phase 2 clinical trials for retinitis pigmentosa (RP). RP is a slowly developing condition that causes the progressive degeneration of rod & cone photoreceptor cells in the retina that over time diminishes night and peripheral vision and eventually leads to blindness. RP is an orphan-designated indication for which...

2009-05-22 10:38:02

Stem cells taken from bone marrow show promise in healing damaged retinal tissue, said researchers at the University of Louisville in Kentucky. The stem cells generated new cells in damaged retinal pigment epithelium, the pigmented cell layer just outside the retina, research led by Dr. Suzanne Ildstad showed. The research could lead to healing vision loss and blindness from age-related macular degeneration and hereditary retinal degeneration, she said. The study is be expanded at the Swine...


Word of the Day
glogg
  • Scandinavian punch made of claret and aquavit with spices and raisins and orange peel and sugar.
This word comes from the Swedish 'glogg,' which is an alteration of 'glodgat,' mulled (wine).
Related